This is quite a fascinating study and is a phase 2 randomised double blind study of cellular treatment of venous ulcers. Patients with non healing venous ulcers of the lower leg were treated with either the vehicle (fibrinogen and thrombin) – control group or with 4 different protocols of the vehicle with fibroblast and keratinocyte […]
An analysis just produced by the Collaborative Transplant Study (CTS) (Newsletter 3; 2012) examined the most frequent cause of death in relation to HLA compatibility in the first 3 years after renal transplantation. The most frequent causes of death were infection (27%), cardiovascular disease (30%) and cancer (8%). It appeared that there were more deaths […]
Facebook have recently teamed up with the NHS Organ Donation Campaign to allow Facebook users to register as organ donors through the site. Users will also be able to share their intentions with their family and friends through the site. The move allows NHS Blood and Transplant to reach a new audience through social media, […]
The September edition of the Transplant Trial Watch is now available on the CET website. Each month, the CET staff select 10 recently published randomised controlled trials in the field of transplantation and summarise the findings and quality. This month, the Trial Watch includes a trial of generic tacrolimus, long-term results from the Tricontinental MMF […]